Publicações

Alemtuzumab Efficacy and Safety Were Maintained over 8 Years in Relapsing-Remitting Multiple Sclerosis Patients with Highly Active Disease from Care-Ms I: Topaz Study Follow-Up

AuthID
P-00R-46N

Author(s)

Limmroth, V

Achiron, A

Bass, AD

Bertolotto, A

Brandes, D

Chinea, A

Garcia, JR

Naismith, RT

Schippling, S

Sharrack, B

Sousa, L

Tintore, M

Traboulsee, A

Uitdehaag, BMJ

Ziemssen, T

Choudhry, Z

Daizadeh, N

Pelletier, D

Document Type

Abstract

Year published

2019

Published

in MULTIPLE SCLEROSIS JOURNAL, ISSN: 1352-4585

Volume: 25, Pages: 535-536 (2)

Conference

35Th Congress of the European-Committee-For-Treatment-And-Research-In-Multiple-Sclerosis (Ectrims) / 24Th Annual Conference of Rehabilitation in Ms, Date: SEP 11-13, 2019, Location: Stockholm, SWEDEN, Sponsors: European Comm Treatment & Res Multiple Sclerosis, Congrex Switzerland Ltd

Indexing